⌘K

Login Start Free

Home/Filings/6-K/0001213900-25-120341

6-K//Foreign company update

PURPLE BIOTECH LTD. 6-K

Accession 0001213900-25-120341

$PPBTCIK 0001614744other

View on SEC.gov Company Profile

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 7:01 AM ET

Size

31.4 KB

Accession

0001213900-25-120341

Documents

2 files

6-K
ea0269148-6k_purple.htmPrimary
REPORT OF FOREIGN PRIVATE ISSUER
EX-99.1
ea026914801ex99-1_purple.htm
PURPLE BIOTECH REPORTS POSITIVE NEW PRECLINICAL DATA DEMONSTRATING MULTI-ARM ANTI-TUMOR ACTIVITY ACROSS TWO CAPTN-3 TRI-SPECIFIC ANTIBODIES AT ESMO IMMUNO-ONCOLOGY CONGRESS 2025

Issuer

PURPLE BIOTECH LTD.

CIK 0001614744

Entity typeother

IncorporatedIsrael

Related Parties

1

filerCIK 0001614744

Filing Metadata

Form type: 6-K
Filed: Dec 10, 7:00 PM ET
Accepted: Dec 11, 7:01 AM ET
Size: 31.4 KB

View on SEC.gov